<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">BMC Infect Dis</journal-id><journal-title-group><journal-title>BMC Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40001039</article-id><article-id pub-id-type="pmc">PMC11863391</article-id>
<article-id pub-id-type="publisher-id">10662</article-id><article-id pub-id-type="doi">10.1186/s12879-025-10662-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Reaching priority populations with different HIV self-testing distribution models in South Africa: an analysis of programme data</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0302-5353</contrib-id><name><surname>Majam</surname><given-names>Mohammed</given-names></name><address><email>mmajam@ezintsha.org</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5117-3732</contrib-id><name><surname>Hatzold</surname><given-names>Karin</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1881-4398</contrib-id><name><surname>Mavhu</surname><given-names>Webster</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Tembo</surname><given-names>Angela</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5622-5423</contrib-id><name><surname>Zishiri</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9105-0182</contrib-id><name><surname>Phiri</surname><given-names>Jane</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8193-817X</contrib-id><name><surname>Conserve</surname><given-names>Donaldson</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2912-8564</contrib-id><name><surname>Haile</surname><given-names>Zelalem</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2785-7640</contrib-id><name><surname>Chidarikire</surname><given-names>Thato</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5499-5523</contrib-id><name><surname>Johnson</surname><given-names>Cheryl C.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0900-9274</contrib-id><name><surname>Moyo</surname><given-names>Sangiwe</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0439-381X</contrib-id><name><surname>Meyer-Rath</surname><given-names>Gesine</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4157-732X</contrib-id><name><surname>Venter</surname><given-names>Francois</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03rp50x72</institution-id><institution-id institution-id-type="GRID">grid.11951.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 1135</institution-id><institution>Ezintsha, a division of the Wits Health Consortium, University of the Witwatersrand, </institution></institution-wrap>Johannesburg, South Africa </aff><aff id="Aff2"><label>2</label>Population Services International, Cape Town, South Africa </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/041y4nv46</institution-id><institution-id institution-id-type="GRID">grid.463169.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 9157 2417</institution-id><institution>Centre for Sexual Health and HIV/AIDS Research (CeSHHAR) Zimbabwe, </institution></institution-wrap>Harare, Zimbabwe </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03svjbs84</institution-id><institution-id institution-id-type="GRID">grid.48004.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9764</institution-id><institution>Department of International Public Health, </institution><institution>Liverpool School of Tropical Medicine, </institution></institution-wrap>Liverpool, UK </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00y4zzh67</institution-id><institution-id institution-id-type="GRID">grid.253615.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9510</institution-id><institution>Department of Prevention and Community Health, </institution><institution>Milken Institute School of Public Health, George Washington University, </institution></institution-wrap>Washington, DC USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01jr3y717</institution-id><institution-id institution-id-type="GRID">grid.20627.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7841</institution-id><institution>Department of Social Medicine, </institution><institution>Ohio University Heritage College of Osteopathic Medicine, </institution></institution-wrap>Dublin, OH USA </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05rfgws98</institution-id><institution-id institution-id-type="GRID">grid.437959.5</institution-id><institution>HIV Prevention Department, </institution><institution>National Department of Health, </institution></institution-wrap>Pretoria, South Africa </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01f80g185</institution-id><institution-id institution-id-type="GRID">grid.3575.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2163 3745</institution-id><institution>Global HIV, Hepatitis and STI Programmes, </institution><institution>World Health Organisation, </institution></institution-wrap>Geneva, Switzerland </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03rp50x72</institution-id><institution-id institution-id-type="GRID">grid.11951.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 1135</institution-id><institution>Department of Internal Medicine, Faculty of Health Sciences, </institution><institution>University of the Witwatersrand, </institution></institution-wrap>Johannesburg, South Africa </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qwgg493</institution-id><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>School of Public Health, </institution><institution>Boston University, </institution></institution-wrap>Boston, MA USA </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>22</volume><issue>Suppl 1</issue><issue-sponsor>Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.</issue-sponsor><elocation-id>981</elocation-id><history><date date-type="received"><day>17</day><month>8</month><year>2023</year></date><date date-type="accepted"><day>14</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par13">As in much of sub-Saharan Africa, substantial HIV testing gaps remain in South Africa, particularly among adult men ages 20&#x02013;35, young people ages 15&#x02013;24 and key populations. Innovative strategies, such as HIV self-testing (HIVST), are needed to reach such under-served populations. We evaluated a range of HIV self-test kit distribution models&#x02019; potential to reach adult men, young people and key populations in South Africa, to inform targeted approaches.</p></sec><sec><title>Methods</title><p id="Par14">This cross-sectional study used data from community and facility-based HIV self-test kit distribution models implemented from October 2017 to April 2020. Self-test kits were distributed as part of the Unitaid-funded Self-Testing AfRica (STAR) programme. Data were collected from individuals who obtained self-test kits through five distribution models. Frequencies and proportions were used to describe the characteristics of the study populations and self-test kit distribution approaches.</p></sec><sec><title>Results</title><p id="Par15">Over 2.5&#x000a0;years, 1 071 065 self-test kits were distributed across the five models. Community-based distribution accounted for 63% of total kits distributed, while the private sector (primarily workplace) accounted for 26%. Distribution at public sector health facilities accounted for 7% and distribution through the key population and secondary distribution models accounted for 2% each. Of those obtaining kits, and for whom we collected previous testing data (<italic>n</italic>&#x02009;=&#x02009;771 612, 72%), 11% had never tested for HIV, 29% had not tested for at least a year, 41% had tested within the last 4&#x02013;12&#x000a0;months and 19% had tested within the preceding three months. More men (64%) than women obtained self-test kits across all distribution models. The majority (80%) of men obtaining self-test kits were aged 20&#x02013;40&#x000a0;years, and primarily received these at public transport terminals (36%), workplaces (18%) and hotspots (14%). A small proportion of men was reached through female sex workers.</p></sec><sec><title>Conclusions</title><p id="Par16">This analysis of programme data enabled us to identify HIV self-test kit distribution models that are best suited to reach specific priority and under-tested populations, particularly adult men and young people. Models/sub-models that reach self-test users where they live, work and spend time, are likely to result in higher HIVST uptake. Study findings can inform future HIVST scale-up in South Africa.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>HIV self-testing</kwd><kwd>Community-based</kwd><kwd>Facility-based</kwd><kwd>Workplace</kwd><kwd>Private sector</kwd><kwd>Key populations</kwd><kwd>South Africa</kwd></kwd-group><funding-group><award-group><funding-source><institution>Unitaid as part of the STAR Initiative</institution></funding-source><award-id>2017-17-SFH-STAR</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2022</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par33">Global (95&#x02013;95-95) targets stipulate that 95% of all people living with the Human Immunodeficiency Virus (HIV) know their HIV status, 95% of all people with diagnosed HIV infection are on sustained treatment and, 95% of all people on HIV treatment are virally suppressed [<xref ref-type="bibr" rid="CR1">1</xref>]. Several countries in sub-Saharan Africa (SSA), the epicentre of the HIV epidemic [<xref ref-type="bibr" rid="CR2">2</xref>], are on track to achieve these targets, demonstrating that they are realistic. Aggregated data however mask substantial variations between both geographic areas and population groups [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. For example, key populations, including female sex workers (FSWs), men who have sex with men (MSM) and people who inject drugs; young people (15&#x02013;24 years-old) and; adult general population men ages 20&#x02013;35 &#x02013; all groups at greatest risk of HIV acquisition &#x02013; continue to lag behind at each stage of the HIV treatment (95&#x02013;95-95) cascade [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par34">Recent global estimates show that compared to women, 1 million, 1.8 million and 1.6 million more men living with HIV do not know their status, know their status but are not on treatment and are not virally suppressed, respectively [<xref ref-type="bibr" rid="CR8">8</xref>]. Lower uptake of HIV testing and treatment among men in SSA is often due to poor utilisation of public sector health facilities, reflecting both structural and social health systems barriers [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>]. Social norms around masculinity that emphasise toughness also contribute to an avoidance of health services [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Further, greater formal and informal employment among men compared to women hinder access due to job insecurity and high indirect and opportunity costs [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par35">Young people experience unique barriers to standard HIV testing services (HTS) that contribute to low testing uptake. These include stigma around HIV testing, fear of disrespect by healthcare providers, concerns over confidentiality and issues of parental/guardian consent [<xref ref-type="bibr" rid="CR9">9</xref>]. Likewise, key population groups experience pervasive and multi-factorial structural barriers to conventional HIV testing services (HTS), including community- and institutional-level stigma and discrimination [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par36">Similar to other SSA settings, variations in HIV testing and treatment access exist in South Africa, home to the highest number of people living with HIV globally [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. As elsewhere, a substantial HIV testing gap remains, particularly among men in general [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>], young people and key populations including FSWs and MSM [<xref ref-type="bibr" rid="CR8">8</xref>]. For example, evidence from district-level data in South Africa showed that MSM and FSWs living with HIV were consistently less likely to know their HIV-positive status than the general population. Innovative solutions and decentralised HTS are therefore required to get to these hard-to-reach and chronically under-tested populations. This is particularly so given a new set of ambitious but achievable targets for 2025 [<xref ref-type="bibr" rid="CR18">18</xref>], and renewed commitment to target specific age and gender groups, key populations and geographic areas to ensure all population groups are equitably served by HIV prevention and treatment services to ultimately end AIDS by 2030 [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par37">HIV self-testing (HIVST), whereby someone performs the test and interprets the result themselves, was until 2020 not widely available in SSA due to concerns about accuracy, acceptability, feasibility, safety and costs [<xref ref-type="bibr" rid="CR20">20</xref>]. It has now been recommended by WHO as an additional approach to increase HIV testing uptake following substantial evidence that it is a safe, acceptable and effective approach to increase access to, and uptake of, HIV testing and subsequently, treatment, care and prevention services [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR30">30</xref>]. HIVST is showing potential to overcome some of the barriers to conventional HIV testing services, including among under-tested populations such as young people, men and key populations in SSA [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR31">31</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par38">Here, we present data from the Population Services International and Ezintsha (Wits Reproductive Health and HIV Institute, South Africa) Self-Testing AfRica (STAR) initiative (October 2017 to April 2020). The initiative assessed the potential of varying HIV self-test kit distribution models and sub-models to reach adult men ages 20&#x02013;35, young people (15&#x02013;24 years-old) and key populations in South Africa. These data would inform targeted approaches needed to reach the remaining 12% of people with HIV in South Africa who are still unaware of their status [<xref ref-type="bibr" rid="CR5">5</xref>].</p></sec><sec id="Sec2"><title>Methods</title><p id="Par39">In 2017, consortium partners in the second phase of the STAR initiative [<xref ref-type="bibr" rid="CR35">35</xref>] conducted HIVST implementation research in Eswatini, Lesotho and South Africa through different distribution models, including workplace-, facility- and community-based approaches [<xref ref-type="bibr" rid="CR36">36</xref>]. Distribution models were identified through various STAR consultative processes (e.g., feasibility studies, discreet choice experiments) [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Distribution approaches were adapted to the specific target populations (e.g., adult men, young people) to be reached. In South Africa, HIVST was also introduced into the private sector and into existing key populations programmes.</p><sec id="Sec3"><title>Description of distribution models and sub-models</title><p id="Par40">HIVST implementation was through five self-test kit distribution models: community-based, private sector, public sector facility, secondary-based and distribution specifically targeting key populations. Three models comprised discrete distribution sub-models (community based, <italic>n</italic>&#x02009;=&#x02009;4; private sector, <italic>n</italic>&#x02009;=&#x02009;5 and secondary-based, <italic>n</italic>&#x02009;=&#x02009;2). Table <xref rid="Tab1" ref-type="table">1</xref> contains a detailed description of the distribution models/sub-models and their implementation. Of note, some sub-models (e.g., ANC, transport hub (public transport terminal), workplace) were intentionally designed to target adult men 20&#x02013;35&#x000a0;years-old, the age group at greatest risk of HIV acquisition in South Africa and other SSA settings [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. All implementation as of December 2020 was subject to COVID-19 adaptations that occurred in the local context.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Description of models and sub-models</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model </th><th align="left">Sub-model</th><th align="left">Description</th></tr></thead><tbody><tr><td align="left" rowspan="4"><bold>Community-based distribution</bold></td><td align="left"><bold>Hotspots</bold></td><td align="left">HIV self-test kits were offered to high-risk populations at hotspots through fixed pop-up sites. Hotspots include high foot traffic areas (e.g., busy walkways, shopping centres). After a trained distributor demonstrated self-test kit use, clients either took the kit home or used it onsite, on their own or with the distributor&#x02019;s assistance. Clients opting to test onsite were given the opportunity to confirm any reactive results</td></tr><tr><td align="left"><bold>Transport hub</bold></td><td align="left">This sub-model&#x02019;s description is the same as that for the hotspot one, with a specific focus on distribution in public transport terminals, including taxi ranks and train stations</td></tr><tr><td align="left"><bold>Door-to-door</bold></td><td align="left">Within a specific mapped community or geographical location, trained distributors and/or counsellors moved from one household to another, offering HIV self-test kits to eligible clients. Clients either used the kit on their own or with the distributor&#x02019;s assistance. Clients who self-reported a reactive result were offered the option to confirm their result onsite or at a nearby facility</td></tr><tr><td align="left"><bold>Integrated HTS (mobile)</bold></td><td align="left">This sub-model involved integrating HIVST into existing mobile HIV testing activities. Clients were offered a choice between HIVST and a blood-based rapid diagnostic test (RDT). Clients were given the opportunity to confirm any reactive results</td></tr><tr><td align="left" rowspan="4"><bold>Private sector distribution</bold></td><td align="left"><bold>General practice (GP) and nurse-led clinics</bold></td><td align="left">Clients attending health services at GP practice or nurse-led clinics were offered HIV testing using HIVST during their consultation. After a demonstration, clients were offered private testing space within the facility to self-test and were asked to self-report their result. Confirmatory testing and ART initiation were available onsite</td></tr><tr><td align="left"><bold>Pharmacy</bold></td><td align="left">Pharmacists and pharmacist assistants at private pharmacies offered self-test kits to clients&#x02009;&#x02265;&#x02009;17&#x000a0;years old seeking services that might suggest HIV risk, including emergency contraception, STI treatment, condoms, lubricants and sexual performance enhancers. After a demonstration, clients could choose to either test onsite or take the kit home. Clients who chose to test onsite were given an opportunity to self-report their result to the pharmacist/pharmacist assistant. All who self-reported a reactive result were offered onsite confirmatory testing</td></tr><tr><td align="left"><bold>Workplace</bold></td><td align="left">This sub-model involved distributing self-test kits in formal workplaces (mining, manufacturing, construction, petroleum, agriculture, security sectors). After a demonstration, clients could choose to either test onsite or take the kit home</td></tr><tr><td align="left"><bold>Workplace Associated Communities</bold></td><td align="left">This sub-model involved kits distribution within communities associated with, or directly surrounding, key workplace sectors such as mining and agriculture. For this sub-model, partners and families of employees were offered tests through outreach programmes. Access to these communities was granted in partnership with the companies and community leaders</td></tr><tr><td align="left"><bold>Public sector facility distribution</bold>
</td><td align="left"><bold>Outpatient Department (OPD)</bold></td><td align="left">Within the hospital outpatient waiting areas, distributors created awareness and provided information on both traditional RDT and HIVST. Clients were then offered the choice to self-test onsite using either a blood or oral-based HIVST kit or having blood-based RDT with a counsellor. Confirmatory testing and ART initiation were available onsite</td></tr><tr><td align="left" rowspan="2"><bold>Secondary-based distribution</bold></td><td align="left"><bold>Antenatal care (ANC)</bold></td><td align="left">After a demonstration and social harm assessment, all first visit ANC attendees were offered self-test kits to take home to support testing of their male sexual partners. A woman could take a HIVST kit for herself to support home disclosure. Consenting women were followed up by telephone or at next visit to acquire information on whether HIVST kit had been used by partner(s)</td></tr><tr><td align="left"><bold>Index testing</bold></td><td align="left">HIVST was offered to newly diagnosed HIV-positive clients (ART clinic) to facilitate partner notification. Telephonic follow-up of HIV-positive index was done to ascertain index partner uptake of HIVST</td></tr><tr><td align="left"><bold>Key population distribution</bold></td><td align="left"><bold>Sex worker</bold></td><td align="left">This sub-model was implemented alongside the Wits Reproductive Health and HIV Institute sex worker programme, which provides various health services to sex workers (SW) at static clinics and at outreach sites. SW were offered up to five self-test kits to take for their network, which would either be their non-client sexual partners, their clients, other SW not accessing HTS, a family member or friend considered by the sex worker to be at elevated risk of HIV. All consenting SW were telephonically followed up to determine usage by their networks. Secondary distribution to male clients and partners was also explored in this sub-model</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec4"><title>Data collection and management</title><p id="Par41">Community health workers and distributors collected data using paper-based forms which were specific to each distribution model/sub-model. Each form included a minimum set of parameters including: age, gender, time since last HIV test, whether the test was assisted or unassisted, and whether the test kit was for a primary or secondary recipient. All data were transcribed onto an electronic case report form by a team of data entry clerks using REDCap, and stored on a secure password-protected server.</p></sec><sec id="Sec5"><title>Data analysis</title><p id="Par42">We used frequencies and percentages to describe the characteristics of HIV distribution and the demographic characteristics of self-test kit recipients by distribution model and sub-model. All analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC).</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>Characteristics of self-test kit distribution and recipients</title><p id="Par43">A total of 1 071 065 self-test kits were distributed across the models/sub-models (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Nearly all distributed kits (99%) were oral-fluid-based, with the remainder (1%) being blood-based/finger prick. Self-test kit distribution peaked in 2018 and 2019 but dropped in 2020 due to lower targets during programme wind-down. The community-based distribution model accounted for nearly two-thirds (63%) of total kits distributed, with the highest number of self-test kit recipients reached through transport hubs (42%) and hotspots (18%) sub-models, while the private sector accounted for just over a quarter (26%) of distributed kits, largely through the workplace (23%) sub-model. Distribution through the public sector facility, secondary (ANC &#x00026; index testing) and key population models accounted for 7%, 2% and 2%, respectively (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). The least number of self-test kits, less than 1% each, were distributed through: Community-based: integrated HTS (mobile) (0.3%) as well as three Private sector sub-models: nurse-led (0.8%), pharmacy (0.6%) and general practitioner (GP) practice (0.04%) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Characteristics of self-test kit distribution (<italic>N</italic>&#x02009;=&#x02009;1 071 065)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model</th><th align="left">n (%)</th></tr></thead><tbody><tr><td align="left">Community-based</td><td align="left">675791 (63.1)</td></tr><tr><td align="left">Private sector</td><td align="left">280505 (26.2)</td></tr><tr><td align="left">Public sector facility</td><td align="left">70785 (6.6)</td></tr><tr><td align="left">Secondary (Antenatal care and Index testing)</td><td align="left">21154 (2.0)</td></tr><tr><td align="left">Key Population</td><td align="left">22830 (2.1)</td></tr><tr><td align="left" colspan="2"><bold>Sub-model</bold></td></tr><tr><td align="left">&#x02003;Community-based: Integrated HTS (mobile)</td><td align="left">3219 (0.3)</td></tr><tr><td align="left">&#x02003;Community-based: Transport Hub</td><td align="left">452316 (42.2)</td></tr><tr><td align="left">&#x02003;Community-based: Door-to-door</td><td align="left">22888 (2.1)</td></tr><tr><td align="left">&#x02003;Community-based: Hotspots</td><td align="left">197368 (18.4)</td></tr><tr><td align="left">&#x02003;Private Sector: Workplace</td><td align="left">243566 (22.7)</td></tr><tr><td align="left">&#x02003;Private Sector: Workplace Associated Communities</td><td align="left">21881 (2.0)</td></tr><tr><td align="left">&#x02003;Private Sector: Pharmacy</td><td align="left">6430 (0.6)</td></tr><tr><td align="left">&#x02003;Private Sector: Nurse-led</td><td align="left">8172 (0.8)</td></tr><tr><td align="left">&#x02003;Private Sector: GP Practice</td><td align="left">456 (0.04)</td></tr><tr><td align="left">&#x02003;Public Sector Facility: Direct distribution (OPD)</td><td align="left">70785 (6.6)</td></tr><tr><td align="left">&#x02003;Secondary: Antenatal care</td><td align="left">14482 (1.4)</td></tr><tr><td align="left">&#x02003;Secondary: Index testing</td><td align="left">6672 (0.6)</td></tr><tr><td align="left">&#x02003;Key Population: Sex Worker</td><td align="left">22830 (2.1)</td></tr><tr><td align="left" colspan="2"><bold>Test Type</bold></td></tr><tr><td align="left">&#x02003;Blood-based</td><td align="left">11825 (1.1)</td></tr><tr><td align="left">&#x02003;Oral-fluid-based</td><td align="left">1059240 (98.9)</td></tr><tr><td align="left" colspan="2"><bold>Year</bold></td></tr><tr><td align="left">&#x02003;2017</td><td align="left">8098 (0.8)</td></tr><tr><td align="left">&#x02003;2018</td><td align="left">567573 (53.0)</td></tr><tr><td align="left">&#x02003;2019</td><td align="left">395268 (36.9)</td></tr><tr><td align="left">&#x02003;2020</td><td align="left">100126 (9.3)</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec8"><title>Self-test kit recipients&#x02019; gender, age by model/sub-model</title><p id="Par44">We analysed characteristics of self-test kit recipients across and within models and sub-models. More males (64%) than females obtained self-test kits across nearly all the five distribution models (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The exception was public sector facility outpatient department (OPD) where more females obtained self-test kits. Across all five distribution models, the majority (80%) of males obtaining self-test kits were aged 20&#x02013;40&#x000a0;years (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The sub-models with the highest proportions of males ages 20&#x02013;40 were transport hub (36%), workplace (18%) and hotspots (14%) (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Of note, a small proportion of men (1%) was reached through female sex workers (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Demographic characteristics of self-test kit recipients by distribution model (<italic>N</italic>&#x02009;=&#x02009;1 071 065)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"><bold>Community-based</bold></th><th align="left"><bold>Key Population</bold></th><th align="left"><bold>Private Sector/workplace</bold></th><th align="left"><bold>Public Sector Facility (OPD)</bold></th><th align="left"><bold>Secondary: ANC &#x00026; Index Testing</bold></th></tr></thead><tbody><tr><td align="left"><bold>Total distributed</bold></td><td align="left">675791 (63.1%)</td><td align="left">22830 (2.1%)</td><td align="left">280505 (26.2%)</td><td align="left">70785 (6.6%)</td><td align="left">21154 (2.0%)</td></tr><tr><td align="left" colspan="6"><bold>Age</bold></td></tr><tr><td align="left">&#x02003;12&#x02013;14</td><td align="left">294 (0.0)</td><td align="left">35 (0.2)</td><td align="left">65 (0.0)</td><td align="left">608 (0.9)</td><td align="left">80 (0.4)</td></tr><tr><td align="left">&#x02003;15&#x02013;19</td><td align="left">21872 (3.2)</td><td align="left">744 (3.3)</td><td align="left">45461 (1.6)</td><td align="left">6393 (9.0)</td><td align="left">615 (2.9)</td></tr><tr><td align="left">&#x02003;20&#x02013;24</td><td align="left">149119 (22.1)</td><td align="left">3125 (13.7)</td><td align="left">59126 (21.1)</td><td align="left">12826 (18.1)</td><td align="left">3480 (16.5)</td></tr><tr><td align="left">&#x02003;25&#x02013;29</td><td align="left">183526 (27.2)</td><td align="left">5741 (25.1)</td><td align="left">62157 22.2)</td><td align="left">13415 (19.0)</td><td align="left">3216 (15.2)</td></tr><tr><td align="left">&#x02003;30&#x02013;34</td><td align="left">141408 (21.0)</td><td align="left">5644 (24.7)</td><td align="left">58477 (20.8)</td><td align="left">10921 (15.4)</td><td align="left">3946 (18.7)</td></tr><tr><td align="left">&#x02003;35&#x02013;39</td><td align="left">89669 (13.3)</td><td align="left">4403 (19.3)</td><td align="left">41058 (14.6)</td><td align="left">7980 (11.3)</td><td align="left">4013 (19.0)</td></tr><tr><td align="left">&#x02003;40&#x02013;44</td><td align="left">43215 (6.4)</td><td align="left">2102 (9.2)</td><td align="left">25887 (9.2)</td><td align="left">5103 (7.2)</td><td align="left">3007 (14.2)</td></tr><tr><td align="left">&#x02003;45&#x02013;49</td><td align="left">24997 (3.7)</td><td align="left">572 (2.5)</td><td align="left">14279 (5.1)</td><td align="left">3645 (5.1)</td><td align="left">1347 (6.4)</td></tr><tr><td align="left">&#x02003;50&#x02009;+&#x02009;</td><td align="left">19565 (2.9)</td><td align="left">362 (1.6)</td><td align="left">13690 (4.9)</td><td align="left">8824 (12.5)</td><td align="left">893 (4.2)</td></tr><tr><td align="left">&#x02003;<sup>a</sup>Missing</td><td align="left">2126 (0.3)</td><td align="left">102 (0.4)</td><td align="left">1270 (0.5)</td><td align="left">1070 (1.5)</td><td align="left">557 (2.6)</td></tr><tr><td align="left" colspan="6"><bold>Sex</bold></td></tr><tr><td align="left">&#x02003;Female</td><td align="left">218281 (32.3)</td><td align="left">11047 (48.4)</td><td align="left">102595 (36.6)</td><td align="left">45018 (63.6)</td><td align="left">2730 (12.9)</td></tr><tr><td align="left">&#x02003;Male</td><td align="left">450851 (66.7)</td><td align="left">11279 (49.4)</td><td align="left">177433 (63.3)</td><td align="left">25308 (35.8)</td><td align="left">17996 (85.1)</td></tr><tr><td align="left">&#x02003;Transgender/other</td><td align="left">1380 (0.2)</td><td align="left">151 (0.7)</td><td align="left">98 (0.0)</td><td align="left">24 (0.0)</td><td align="left">20 (0.1)</td></tr><tr><td align="left">&#x02003;<sup>a</sup>Missing</td><td align="left">5279 (0.8)</td><td align="left">353 (1.6)</td><td align="left">379 (0.1)</td><td align="left">435 (0.6)</td><td align="left">408 (1.9)</td></tr><tr><td align="left" colspan="6"><bold>Previous Testing</bold></td></tr><tr><td align="left">&#x02003;0&#x02013;3&#x000a0;months</td><td align="left">97314 (14.4)</td><td align="left">684 (3.0)</td><td align="left">27209 (9.7)</td><td align="left">19350 (27.3)</td><td align="left">1608 (7.6)</td></tr><tr><td align="left">&#x02003;4&#x02013;12&#x000a0;months</td><td align="left">208144 (30.8)</td><td align="left">822 (3.6)</td><td align="left">79944 (28.5)</td><td align="left">28077 (39.7)</td><td align="left">2750 (13)</td></tr><tr><td align="left">&#x02003;&#x0003e;&#x02009;12 months</td><td align="left">123670 (18.3)</td><td align="left">548 (2.4)</td><td align="left">82468 (29.4)</td><td align="left">14846 (21)</td><td align="left">994 (4.7)</td></tr><tr><td align="left">&#x02003;Never tested</td><td align="left">54063 (8.0)</td><td align="left">137 (0.6)</td><td align="left">22721 (8.1)</td><td align="left">5480 (7.7)</td><td align="left">783 (3.7)</td></tr><tr><td align="left">&#x02003;<sup>a</sup>Missing</td><td align="left">192600 (28.5)</td><td align="left">20639 (90.4)</td><td align="left">68163 (24.3)</td><td align="left">3032 (4.3)</td><td align="left">15019 (71.0)</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Missing data age (<italic>n</italic>&#x02009;=&#x02009;5125); sex (<italic>n</italic>&#x02009;=&#x02009;6854); previous testing (<italic>n</italic>&#x02009;=&#x02009;299453)</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Demographic characteristics of self-test kit recipients by distribution sub-model (<italic>N</italic>&#x02009;=&#x02009;1 071 065)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left"/><td align="left"><bold>ANC</bold></td><td align="left"><bold>OPD</bold></td><td align="left"><bold>Door-to-door</bold></td><td align="left"><bold>Hotspots</bold></td><td align="left"><bold>GP Practice</bold></td><td align="left"><bold>Index testing</bold></td><td align="left"><bold>Integrated HTS (mobile)</bold></td></tr><tr><td align="left"><bold>Total distributed</bold></td><td align="left">14482 (1.4%)</td><td align="left">70785 (6.6%)</td><td align="left">22888 (2.1%)</td><td align="left">197368 (18.4%)</td><td align="left">456 (0.0%)</td><td align="left">6672 (0.6%)</td><td align="left">3219 (0.3%)</td></tr><tr><td align="left" colspan="8"><bold>Age</bold></td></tr><tr><td align="left">&#x02003;12&#x02013;14</td><td align="left">0 (0.0)</td><td align="left">608 (0.9)</td><td align="left">6 (0.0)</td><td align="left">85 (0.0)</td><td align="left">0 (0.0)</td><td align="left">78 (1.2)</td><td align="left">13 (0.4)</td></tr><tr><td align="left">&#x02003;15&#x02013;19</td><td align="left">199 (1.4)</td><td align="left">6393 (9.0)</td><td align="left">985 (4.3)</td><td align="left">10791 (5.5)</td><td align="left">18 (4.0)</td><td align="left">138 (2.1)</td><td align="left">259 (8.0)</td></tr><tr><td align="left">&#x02003;20&#x02013;24</td><td align="left">1640 (11.3)</td><td align="left">12826 (18.1)</td><td align="left">4338 (19.0)</td><td align="left">45492 (23.0)</td><td align="left">57 (12.5)</td><td align="left">361 (5.4)</td><td align="left">663 (20.6)</td></tr><tr><td align="left">&#x02003;25&#x02013;29</td><td align="left">4027 (27.8)</td><td align="left">13415 (19.0)</td><td align="left">5155 (22.5)</td><td align="left">47691 (24.2)</td><td align="left">100 (21.9)</td><td align="left">1038 (15.6)</td><td align="left">734 (22.8)</td></tr><tr><td align="left">&#x02003;30&#x02013;34</td><td align="left">4042 (27.9)</td><td align="left">10921 (15.4)</td><td align="left">4458 (19.5)</td><td align="left">36658 (18.6)</td><td align="left">96 (21.1)</td><td align="left">1502 (22.5)</td><td align="left">579 (18.0)</td></tr><tr><td align="left">&#x02003;35&#x02013;39</td><td align="left">2661 (18.4)</td><td align="left">7980 (11.3)</td><td align="left">3102 (13.6)</td><td align="left">24409 (12.4)</td><td align="left">62 (13.6)</td><td align="left">1473 (22.1)</td><td align="left">381 (11.8)</td></tr><tr><td align="left">&#x02003;40&#x02013;44</td><td align="left">1048 (7.2)</td><td align="left">5103 (7.2)</td><td align="left">1935 (8.5)</td><td align="left">14778 (7.5)</td><td align="left">56 (12.3)</td><td align="left">983 (14.7)</td><td align="left">240 (7.5)</td></tr><tr><td align="left">&#x02003;45&#x02013;49</td><td align="left">310 (2.1)</td><td align="left">3645 (5.1)</td><td align="left">1044 (4.6)</td><td align="left">8153 (4.1)</td><td align="left">32 (7.0)</td><td align="left">553 (8.3)</td><td align="left">151 (4.7)</td></tr><tr><td align="left">&#x02003;50&#x02009;+&#x02009;</td><td align="left">123 (0.8)</td><td align="left">8824 (12.5)</td><td align="left">1162 (5.1)</td><td align="left">8266 (4.2)</td><td align="left">28 (6.1)</td><td align="left">440 (6.6)</td><td align="left">197 (6.1)</td></tr><tr><td align="left">&#x02003;Missing</td><td align="left">432 (3.0)</td><td align="left">1070 (1.5)</td><td align="left">703 (3.1)</td><td align="left">1045 (0.5)</td><td align="left">7 (1.5)</td><td align="left">106 (1.6)</td><td align="left">2 (0.1)</td></tr><tr><td align="left" colspan="8"><bold>Gender</bold></td></tr><tr><td align="left">&#x02003;Female</td><td align="left">0 (0.0)</td><td align="left">45018 (63.6)</td><td align="left">8052 (35.2)</td><td align="left">88067 (44.6)</td><td align="left">254 (55.7)</td><td align="left">1578 (23.7)</td><td align="left">1306 (40.6)</td></tr><tr><td align="left">&#x02003;Male</td><td align="left">14248 (98.4)</td><td align="left">25308 (35.8)</td><td align="left">14545 (63.6)</td><td align="left">107941 (54.7)</td><td align="left">200 (43.9)</td><td align="left">4947 (74.2)</td><td align="left">1906 (59.2)</td></tr><tr><td align="left">&#x02003;Transgender/other</td><td align="left">0 (0.0)</td><td align="left">24 (0.0)</td><td align="left">20 (0.1)</td><td align="left">129 (0.1)</td><td align="left">0 (0.0)</td><td align="left">2 (0.0)</td><td align="left">1 (0.0)</td></tr><tr><td align="left">&#x02003;Missing</td><td align="left">234 (1.6)</td><td align="left">435 (0.6)</td><td align="left">271 (1.2)</td><td align="left">1231 (0.6)</td><td align="left">2 (0.4)</td><td align="left">145 (2.2)</td><td align="left">6 (0.2)</td></tr><tr><td align="left" colspan="8"><bold>Previous Testing</bold></td></tr><tr><td align="left">&#x02003;0&#x02013;3&#x000a0;months</td><td align="left">0 (0.0)</td><td align="left">19350 (27.3)</td><td align="left">1706 (7.5)</td><td align="left">15775 (8.0)</td><td align="left">55 (12.1)</td><td align="left">3 (0.0)</td><td align="left">283 (8.8)</td></tr><tr><td align="left">&#x02003;4&#x02013;12&#x000a0;months</td><td align="left">0 (0.0)</td><td align="left">28077 (39.7)</td><td align="left">5301 (23.2)</td><td align="left">63841 (32.3)</td><td align="left">161 (35.3)</td><td align="left">0 (0.0)</td><td align="left">1520 (47.2)</td></tr><tr><td align="left">&#x02003;&#x0003e;&#x02009;12&#x000a0;months</td><td align="left">0 (0.0)</td><td align="left">14846 (21.0)</td><td align="left">5990 (26.2)</td><td align="left">44372 (22.5)</td><td align="left">139 (30.5)</td><td align="left">0 (0.0)</td><td align="left">783 (24.3)</td></tr><tr><td align="left">&#x02003;Never tested</td><td align="left">0 (0.0)</td><td align="left">5480 (7.7)</td><td align="left">4071 (17.8)</td><td align="left">8791 (4.5)</td><td align="left">35 (7.7)</td><td align="left">0 (0.0)</td><td align="left">211 (6.6)</td></tr><tr><td align="left">&#x02003;Missing</td><td align="left">14482 (100)</td><td align="left">3032 (4.3)</td><td align="left">5820 (25.4)</td><td align="left">64589 (32.7)</td><td align="left">66 (14.5)</td><td align="left">6669 (100)</td><td align="left">422 (13.1)</td></tr><tr><td align="left"/><td align="left"><bold>Nurse-led</bold></td><td align="left"><bold>Pharmacy</bold></td><td align="left"><bold>Sex Worker</bold></td><td align="left"><bold>Transport Hub</bold></td><td align="left" colspan="2"><bold>Workplace</bold></td><td align="left"><bold>Workplace Associated Communities</bold></td></tr><tr><td align="left"><bold>Total distributed</bold></td><td align="left">8172 (0.8%)</td><td align="left">6430 (0.6%)</td><td align="left">22830 (2.1%)</td><td align="left">452316 (42.2%)</td><td align="left" colspan="2">243566 (22.7%)</td><td align="left">21881 (2.0%)</td></tr><tr><td align="left" colspan="8"><bold>Age</bold></td></tr><tr><td align="left">&#x02003;12&#x02013;14</td><td align="left">59 (0.7)</td><td align="left">3 (0.0)</td><td align="left">37 (0.2)</td><td align="left">189 (0.0)</td><td align="left" colspan="2">3 (0.0)</td><td align="left">1 (0.0)</td></tr><tr><td align="left">&#x02003;15&#x02013;19</td><td align="left">512 (6.3)</td><td align="left">173 (2.7)</td><td align="left">777 (3.4)</td><td align="left">11019 (2.4)</td><td align="left" colspan="2">3844 (1.6)</td><td align="left">1097 (5.0)</td></tr><tr><td align="left">&#x02003;20&#x02013;24</td><td align="left">1138 (13.9)</td><td align="left">968 (15.1)</td><td align="left">3285 (14.4)</td><td align="left">96699 (21.4)</td><td align="left" colspan="2">34726 (14.3)</td><td align="left">4164 (19.0)</td></tr><tr><td align="left">&#x02003;25&#x02013;29</td><td align="left">1619 (19.8)</td><td align="left">1470 (22.9)</td><td align="left">6105 (26.7)</td><td align="left">127542 (28.2)</td><td align="left" colspan="2">59051 (24.2)</td><td align="left">5108 (23.3)</td></tr><tr><td align="left">&#x02003;30&#x02013;34</td><td align="left">1237 (15.1)</td><td align="left">1336 (20.8)</td><td align="left">5993 (26.3)</td><td align="left">98363 (21.7)</td><td align="left" colspan="2">55907 (23.0)</td><td align="left">4304 (19.7)</td></tr><tr><td align="left">&#x02003;35&#x02013;39</td><td align="left">1050 (12.8)</td><td align="left">976 (15.2)</td><td align="left">3322 (14.6)</td><td align="left">60575 (13.4)</td><td align="left" colspan="2">39023 (16.0)</td><td align="left">2827 (12.9)</td></tr><tr><td align="left">&#x02003;40&#x02013;44</td><td align="left">692 (8.5)</td><td align="left">535 (8.3)</td><td align="left">2216 (9.7)</td><td align="left">25304 (5.6)</td><td align="left" colspan="2">24662 (10.1)</td><td align="left">1762 (8.1)</td></tr><tr><td align="left">&#x02003;45&#x02013;49</td><td align="left">524 (6.4)</td><td align="left">290 (4.5)</td><td align="left">607 (2.7)</td><td align="left">15006 (3.3)</td><td align="left" colspan="2">13466 (5.5)</td><td align="left">1059 (4.8)</td></tr><tr><td align="left">&#x02003;50&#x02009;+&#x02009;</td><td align="left">1072 (13.1)</td><td align="left">313 (4.9)</td><td align="left">379 (1.7)</td><td align="left">17246 (3.8)</td><td align="left" colspan="2">12303 (5.1)</td><td align="left">1547 (7.1)</td></tr><tr><td align="left">&#x02003;Missing</td><td align="left">269 (3.3)</td><td align="left">366 (5.7)</td><td align="left">109 (0.5)</td><td align="left">373 (0.1)</td><td align="left" colspan="2">581 (0.2)</td><td align="left">12 (0.1)</td></tr><tr><td align="left" colspan="8"><bold>Gender</bold></td></tr><tr><td align="left">&#x02003;Female</td><td align="left">5126 (62.7)</td><td align="left">3463 (53.9)</td><td align="left">11128 (48.7)</td><td align="left">116852 (25.8)</td><td align="left" colspan="2">91655 (37.6)</td><td align="left">9470 (43.3)</td></tr><tr><td align="left">&#x02003;Male</td><td align="left">3017 (36.9)</td><td align="left">2956 (46.0)</td><td align="left">11157 (48.9)</td><td align="left">330563 (73.1)</td><td align="left" colspan="2">151475 (62.2)</td><td align="left">12306 (56.2)</td></tr><tr><td align="left">&#x02003;Transgender/other</td><td align="left">0 (0.0)</td><td align="left">4 (0.1)</td><td align="left">169 (0.7)</td><td align="left">1210 (0.3)</td><td align="left" colspan="2">94 (0.0)</td><td align="left">20 (0.1)</td></tr><tr><td align="left">&#x02003;Missing</td><td align="left">29 (0.4)</td><td align="left">7 (0.1)</td><td align="left">376 (1.7)</td><td align="left">3691 (0.8)</td><td align="left" colspan="2">342 (0.1)</td><td align="left">85 (0.4)</td></tr><tr><td align="left" colspan="8"><bold>Previous Testing</bold></td></tr><tr><td align="left">&#x02003;0&#x02013;3&#x000a0;months</td><td align="left">354 (4.3)</td><td align="left">1092 (17.0)</td><td align="left">690 (3.0)</td><td align="left">81077 (17.9)</td><td align="left" colspan="2">23639 (9.7)</td><td align="left">2714 (12.4)</td></tr><tr><td align="left">&#x02003;4&#x02013;12&#x000a0;months</td><td align="left">2500 (30.6)</td><td align="left">2112 (32.8)</td><td align="left">833 (3.7)</td><td align="left">135779 (30.0)</td><td align="left" colspan="2">68953 (28.3)</td><td align="left">9313 (42.6)</td></tr><tr><td align="left">&#x02003;&#x0003e;&#x02009;12&#x000a0;months</td><td align="left">2989 (36.6)</td><td align="left">1446 (22.5)</td><td align="left">559 (2.5)</td><td align="left">69205 (15.3)</td><td align="left" colspan="2">71441 (29.3)</td><td align="left">6602 (30.2)</td></tr><tr><td align="left">&#x02003;Never tested</td><td align="left">1044 (12.8)</td><td align="left">649 (10.1)</td><td align="left">128 (0.6)</td><td align="left">40409 (8.9)</td><td align="left" colspan="2">19079 (7.8)</td><td align="left">2357 (10.8)</td></tr><tr><td align="left">&#x02003;Missing</td><td align="left">1285 (15.7)</td><td align="left">1131 (17.6)</td><td align="left">20574 (90.2)</td><td align="left">125846 (27.8)</td><td align="left" colspan="2">60454 (24.8)</td><td align="left">895 (4.1)</td></tr></tbody></table></table-wrap></p><p id="Par45">Nearly a quarter (<italic>n</italic>&#x02009;=&#x02009;261 846, 24%) of all self-test kit recipients were adolescents and young people aged 15&#x02013;24&#x000a0;years (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The sub-models with the highest proportions of 15&#x02013;24&#x000a0;year-olds were transport hub (10%), hotspots (5%) and workplace (4%) (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).</p></sec><sec id="Sec9"><title>Self-test kit recipients&#x02019; previous testing by model</title><p id="Par46">Of those obtaining self-test kits and for whom we collected previous testing data (<italic>n</italic>&#x02009;=&#x02009;771 612, 72%), 11% had never tested for HIV, 29% had not tested for at least a year, 41% had tested within the last 4&#x02013;12&#x000a0;months and 19% had tested within the preceding three months (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Compared to the secondary (ANC and index testing) (4%) and key population (1%) models, the private sector, community-based and health facility OPD distribution approaches reached relatively high numbers of individuals with HIVST who had never tested for HIV (8% for all three models) (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Of note, key population and secondary (ANC and index testing) models had a high number of missing data for this variable (90% and 71%, respectively) (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).</p></sec></sec><sec id="Sec10"><title>Discussion</title><p id="Par47">Our analysis of programme data for the period October 2017 to April 2020 has shown a high rate of HIV self-test kit distribution (&#x0003e;&#x02009;1 million kits over 2.5 years) in South Africa across a variety of models and during routine service provision. These data add to the growing evidence on the feasibility and acceptability of this testing approach. The majority of kits (63%) were distributed through the community-based distribution model, mostly via the transport hub and hotspots sub-models, highlighting the practicality of using these approaches for further scale up.</p><p id="Par48">Across models, 11% of self-test kit recipients for whom we collected previous testing data had never tested for HIV, highlighting the importance of HIV self-testing in reaching previously untested individuals, some of whom may not have tested otherwise [<xref ref-type="bibr" rid="CR9">9</xref>]. While the proportion of first-time testers reached in this programme appears lower than reported in previous studies [<xref ref-type="bibr" rid="CR9">9</xref>], this likely reflects how challenging reaching this group might become as countries are nearing achievement of global targets. When considering the high volume of kits distributed, however, this suggests that wide-scale HIVST programming continues to be an important strategy for SSA in general and South Africa, specifically in working towards achieving the first 95 of the 95&#x02013;95-95 targets [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par49">Data on models/sub-models that reach higher proportions of specific population groups will be critical in closing the HIV testing gap that remains, among men in general [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>] and key populations including sex workers and MSM [<xref ref-type="bibr" rid="CR8">8</xref>]. Achieving greater coverage of diagnosis, treatment and viral suppression among men is not only important for their own health, but also reduces the risk of HIV transmission to female partners [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. HIVST strategies that reached men were a key focus of this programme and models that witnessed the highest number of kits distributed were transport hub, workplace and hotspots. These findings are unsurprising as the programme conducted specific outreach to men, and previous studies have reported similar results [<xref ref-type="bibr" rid="CR9">9</xref>]. The workplace model implemented in this programme is now recognised as a particularly useful way to reach men [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Given that men are recognised i) as constituting the greatest gap in HIV services in SSA in general and South Africa, specifically [<xref ref-type="bibr" rid="CR2">2</xref>], ii) for avoiding health facilities [<xref ref-type="bibr" rid="CR42">42</xref>], using a combination of non-facility-based testing approaches to reach this group is an urgent necessity [<xref ref-type="bibr" rid="CR39">39</xref>].</p><p id="Par50">We also explored the feasibility of reaching men with HIVST through their female sexual partners. A small proportion of males were reached with HIVST through female sex workers. This secondary distribution model has not yet been strongly demonstrated by programme data. Our data add to the growing evidence on how HIVST could be an effective tool to improve access to, and frequency of, HIV testing among sex workers&#x02019; clients and other sexual partners [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. However, given the potential risks HIVST may pose to sex workers, who are particularly vulnerable to violence [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR44">44</xref>] it is crucial to involve sex worker networks and communities in the design of these approaches.</p><p id="Par51">Adolescents and young people (ages 15&#x02013;24) continue to be an important group to be reached with HIV services including HIV testing in SSA. Here, six in seven new HIV infections among adolescents (aged 15&#x02013;19 years) are among girls, and young women (ages 15&#x02013;24) are twice as likely to be living with HIV than their male counterparts [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Further, adolescent girls and young women (AGYW, ages 15&#x02013;24) accounted for 25% of HIV infections in 2020, despite representing just 10% of the population [<xref ref-type="bibr" rid="CR8">8</xref>]. AGYW therefore need access to HIVST throughout periods of risk and, in the form of flexible delivery. Although we are unable to delineate the sub-models that were effective at specifically reaching AGYW, programme data showed HIVST&#x02019;s utility in reaching adolescents and young people overall, with 24% of all distributions reaching this group. The sub-models with the highest proportions of 15&#x02013;24&#x000a0;year-olds were transport hub, hotspots and workplace; these can be utilised going forward.</p><p id="Par52">HIVST may be a critical entry point for other sexual and reproductive health and HIV services for young people, including family planning and pre-exposure prophylaxis (PrEP). WHO now recommends self-testing as an important tool for differentiated service delivery of PrEP (oral PrEP and Dapivirine Vaginal Ring) both to optimise delivery and enable more people to access PrEP [<xref ref-type="bibr" rid="CR24">24</xref>]. Further implementation research is needed to guide programmes on how best to scale-up this strategy and measure its impact toward PrEP targets and the global goal to reduce annual new HIV infections to 370,000 by 2025 [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par53">With a high number of distributed kits (&#x0003e;&#x02009;1 million), we were able to make substantial inferences. A limitation is that self-test kit distribution approaches used were intentionally designed to target specific priority populations such as adult men who are generally less likely to have tested compared to women; thus, these findings should be considered in this context and other programmes without targeting may have different results. In addition, some sub-models had a high number of missing data for some variables, which made it difficult to derive certain inferences. Also, due to pragmatic reasons, we followed up the HIVST result for some clients/sub-models and not others, a factor which influences observed positivity rates. Finally, we did not explore the findings in-depth (e.g., qualitatively), which would have provided context and nuances.</p></sec><sec id="Sec11"><title>Conclusions</title><p id="Par54">This analysis of programme data enabled us to identify self-test kit distribution models which could be used to reach men 20&#x02013;35&#x000a0;years old and young people, groups at greatest risk of HIV acquisition in both South Africa and much of SSA. The data suggest that models/sub-models that reach targeted groups where they live, work and spend time, are likely to result in higher HIVST uptake. Study findings will be important in ensuring the scale-up of HIVST in South Africa is tailored to meet the needs of different population groups. Study findings are relevant to all programmes, government departments and implementers involved in scaling up HIVST.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AGYW </term><def><p id="Par17">Adolescent girls and young women</p></def></def-item><def-item><term>ANC</term><def><p id="Par18">Antenatal care</p></def></def-item><def-item><term>ART</term><def><p id="Par19">Antiretroviral therapy</p></def></def-item><def-item><term>FSW</term><def><p id="Par20">Female sex worker</p></def></def-item><def-item><term>GP</term><def><p id="Par21">General practitioner</p></def></def-item><def-item><term>HIV</term><def><p id="Par22">Human immunodeficiency virus</p></def></def-item><def-item><term>HIVST</term><def><p id="Par23">HIV self-testing</p></def></def-item><def-item><term>HTS</term><def><p id="Par24">HIV testing services</p></def></def-item><def-item><term>MSM</term><def><p id="Par25">Men who have sex with men</p></def></def-item><def-item><term>OPD</term><def><p id="Par26">Outpatient department</p></def></def-item><def-item><term>PrEP</term><def><p id="Par27">Pre-exposure prophylaxis</p></def></def-item><def-item><term>RDT</term><def><p id="Par28">Rapid Diagnostic Test</p></def></def-item><def-item><term>SSA </term><def><p id="Par29">Sub-Saharan Africa</p></def></def-item><def-item><term>STAR</term><def><p id="Par30">Self-Testing AfRica</p></def></def-item><def-item><term>STI</term><def><p id="Par31">Sexually Transmitted Infection</p></def></def-item><def-item><term>WHO</term><def><p id="Par32">World Health Organisation</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The study was run by Ezintsha (Wits Reproductive Health and HIV Institute) staff and undertaken in collaboration with the NDOH, UNITAID, PSI, SFH, CHAI, WHO and the HIV Self-Testing Africa Research Consortium institutions. The authors would like to thank all their implementing partners and study participants in South Africa.</p><sec id="FPar1"><title>About this supplement</title><p id="Par55">This article has been published as part of BMC Infectious Diseases Volume 22 Supplement 1 2021: Innovating with HIV self-testing for impact in southern Africa: Lessons learned from the STAR (Self-Testing AfRica) Initiative. The full contents of the supplement are available at <ext-link ext-link-type="uri" xlink:href="https://bmcinfectdis.biomedcentral.com/articles/supplements/volume-22-supplement-1">https://bmcinfectdis.biomedcentral.com/articles/supplements/volume-22-supplement-1</ext-link>.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>MM, KH and FV were responsible for the conceptual design of the study. MM, AT, VZ, JP, TC, SM, KH and FV contributed to the initial design of the study. MM, AT, VZ, and JP collected data. MM, JP, DC, and ZH cleaned and analysed data. TC, CCJ, SM, KH, GMR and FV provided guidance throughout data collection, cleaning, and analysis. MM, KH, and WM wrote the paper, and all authors were involved in the review of drafts. All authors have approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Unitaid as part of the STAR Initiative, grant number 2017&#x02013;17-SFH-STAR. Unitaid is a hosted partnership of the World Health Organisation. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par56">Ethical approval was granted by the University of the Witwatersrand Human Research Ethics Committee (#180405). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The programme put in place a range of measures to deal with any social harms, including engaging social harm specialists, psychologists and law enforcement agencies. Potential social harms were explained to HIVST kit recipients, together with measures to take if such harms occurred, including contacting study counsellors using toll free numbers.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par57">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par58">The authors declare that they have no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">UNAIDS: Understanding Fast-Track: Accelerating Action to End the AIDS Epidemic by 2030. Geneva: Joint United Nations Programme on HIV/AIDS; 2015. Available: <ext-link ext-link-type="uri" xlink:href="https://www.unaids.org/en/resources/documents/2015/201506_JC2743_Understanding_FastTrack">https://www.unaids.org/en/resources/documents/2015/201506_JC2743_Understanding_FastTrack</ext-link>.</mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Cornell</surname><given-names>M</given-names></name><name><surname>Majola</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>LF</given-names></name><name><surname>Dubula-Majola</surname><given-names>V</given-names></name></person-group><article-title>HIV services in sub-Saharan Africa: the greatest gap is men</article-title><source>Lancet</source><year>2021</year><volume>397</volume><issue>10290</issue><fpage>2130</fpage><lpage>2132</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)01163-6</pub-id><pub-id pub-id-type="pmid">34087108</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Cornell M, Majola M, Johnson LF, Dubula-Majola V. HIV services in sub-Saharan Africa: the greatest gap is men. Lancet. 2021;397(10290):2130&#x02013;2.<pub-id pub-id-type="pmid">34087108</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Giguere</surname><given-names>K</given-names></name><name><surname>Eaton</surname><given-names>JW</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Johnson</surname><given-names>LF</given-names></name><name><surname>Johnson</surname><given-names>CC</given-names></name><name><surname>Ehui</surname><given-names>E</given-names></name><name><surname>Jahn</surname><given-names>A</given-names></name><name><surname>Wanyeki</surname><given-names>I</given-names></name><name><surname>Mbofana</surname><given-names>F</given-names></name><name><surname>Bakiono</surname><given-names>F</given-names></name><etal/></person-group><article-title>Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000&#x02013;20: a modelling study using survey and HIV testing programme data</article-title><source>Lancet HIV</source><year>2021</year><volume>8</volume><issue>5</issue><fpage>e284</fpage><lpage>e293</lpage><pub-id pub-id-type="doi">10.1016/S2352-3018(20)30315-5</pub-id><pub-id pub-id-type="pmid">33667411</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Giguere K, Eaton JW, Marsh K, Johnson LF, Johnson CC, Ehui E, Jahn A, Wanyeki I, Mbofana F, Bakiono F, et al. Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000&#x02013;20: a modelling study using survey and HIV testing programme data. Lancet HIV. 2021;8(5):e284&#x02013;93.<pub-id pub-id-type="pmid">33667411</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">UNAIDS: IN DANGER: UNAIDS Global AIDS Update 2022. Geneva: Joint United Nations Programme on HIV/AIDS; 2022. Available: <ext-link ext-link-type="uri" xlink:href="https://www.unaids.org/en/resources/documents/2022/in-danger-global-aids-update">https://www.unaids.org/en/resources/documents/2022/in-danger-global-aids-update</ext-link>.</mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">UNAIDS: The path that ends AIDS: UNAIDS Global AIDS Update 2023. Geneva: Joint United Nations Programme on HIV/AIDS; 2023. Available: <ext-link ext-link-type="uri" xlink:href="https://www.unaids.org/en/resources/documents/2023/global-aids-update-2023">https://www.unaids.org/en/resources/documents/2023/global-aids-update-2023</ext-link>.</mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Mavhu W, Neuman M, Hatzold K, Buzuzi S, Maringwa G, Chabata ST, Mangenah C, Taruberekera N, Madidi N, Munjoma M et al: Innovative demand creation strategies to increase voluntary medical male circumcision uptake: a pragmatic randomised controlled trial in Zimbabwe. BMJ Glob Health 2021, 6(Suppl 4).</mixed-citation></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>FM</given-names></name><name><surname>Machingura</surname><given-names>F</given-names></name><name><surname>Ali</surname><given-names>MS</given-names></name><name><surname>Chabata</surname><given-names>ST</given-names></name><name><surname>Takaruza</surname><given-names>A</given-names></name><name><surname>Dirawo</surname><given-names>J</given-names></name><name><surname>Makamba</surname><given-names>M</given-names></name><name><surname>Hove</surname><given-names>T</given-names></name><name><surname>Bansi-Matharu</surname><given-names>L</given-names></name><name><surname>Matambanadzo</surname><given-names>P</given-names></name><etal/></person-group><article-title>A risk-differentiated, community-led intervention to strengthen uptake and engagement with HIV prevention and care cascades among female sex workers in Zimbabwe (AMETHIST): a cluster randomised trial</article-title><source>Lancet Glob Health</source><year>2024</year><volume>12</volume><issue>9</issue><fpage>e1424</fpage><lpage>e1435</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(24)00235-3</pub-id><pub-id pub-id-type="pmid">39151978</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Cowan FM, Machingura F, Ali MS, Chabata ST, Takaruza A, Dirawo J, Makamba M, Hove T, Bansi-Matharu L, Matambanadzo P, et al. A risk-differentiated, community-led intervention to strengthen uptake and engagement with HIV prevention and care cascades among female sex workers in Zimbabwe (AMETHIST): a cluster randomised trial. Lancet Glob Health. 2024;12(9):e1424&#x02013;35.<pub-id pub-id-type="pmid">39151978</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">UNAIDS: UNAIDS Global AIDS Update-Confronting inequalities: lessons for pandemic responses from 40 years of AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2021. Available: <ext-link ext-link-type="uri" xlink:href="https://www.unaids.org/en/resources/documents/2021/2021-global-aids-update">https://www.unaids.org/en/resources/documents/2021/2021-global-aids-update</ext-link>.</mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Hatzold K, Gudukeya S, Mutseta MN, Chilongosi R, Nalubamba M, Nkhoma C, Munkombwe H, Munjoma M, Mkandawire P, Mabhunu V et al: HIV self-testing: breaking the barriers to uptake of testing among men and adolescents in sub-Saharan Africa, experiences from STAR demonstration projects in Malawi, Zambia and Zimbabwe. J Int AIDS Soc 2019, 22 Suppl 1(Suppl Suppl 1):e25244.</mixed-citation></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Cornell</surname><given-names>M</given-names></name><name><surname>Cox</surname><given-names>V</given-names></name><name><surname>Wilkinson</surname><given-names>L</given-names></name></person-group><article-title>Public health blindness towards men in HIV programmes in Africa</article-title><source>Trop Med Int Health</source><year>2015</year><volume>20</volume><issue>12</issue><fpage>1634</fpage><lpage>1635</lpage><pub-id pub-id-type="doi">10.1111/tmi.12593</pub-id><pub-id pub-id-type="pmid">26325025</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Cornell M, Cox V, Wilkinson L. Public health blindness towards men in HIV programmes in Africa. Trop Med Int Health. 2015;20(12):1634&#x02013;5.<pub-id pub-id-type="pmid">26325025</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Mavhu</surname><given-names>W</given-names></name><name><surname>Makamba</surname><given-names>M</given-names></name><name><surname>Hatzold</surname><given-names>K</given-names></name><name><surname>Maringwa</surname><given-names>G</given-names></name><name><surname>Takaruza</surname><given-names>A</given-names></name><name><surname>Mutseta</surname><given-names>M</given-names></name><name><surname>Ncube</surname><given-names>G</given-names></name><name><surname>Cowan</surname><given-names>FM</given-names></name><name><surname>Sibanda</surname><given-names>EL</given-names></name></person-group><article-title>Preferences for oral-fluid-based or blood-based HIV self-testing and provider-delivered testing: an observational study among different populations in Zimbabwe</article-title><source>BMC Infect Dis</source><year>2023</year><volume>22</volume><issue>Suppl 1</issue><fpage>973</fpage><pub-id pub-id-type="doi">10.1186/s12879-023-08624-y</pub-id><pub-id pub-id-type="pmid">37848810</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Mavhu W, Makamba M, Hatzold K, Maringwa G, Takaruza A, Mutseta M, Ncube G, Cowan FM, Sibanda EL. Preferences for oral-fluid-based or blood-based HIV self-testing and provider-delivered testing: an observational study among different populations in Zimbabwe. BMC Infect Dis. 2023;22(Suppl 1):973.<pub-id pub-id-type="pmid">37848810</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Dovel</surname><given-names>K</given-names></name><name><surname>Yeatman</surname><given-names>S</given-names></name><name><surname>Watkins</surname><given-names>S</given-names></name><name><surname>Poulin</surname><given-names>M</given-names></name></person-group><article-title>Men's heightened risk of AIDS-related death: the legacy of gendered HIV testing and treatment strategies</article-title><source>AIDS</source><year>2015</year><volume>29</volume><issue>10</issue><fpage>1123</fpage><lpage>1125</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000000655</pub-id><pub-id pub-id-type="pmid">26035315</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Dovel K, Yeatman S, Watkins S, Poulin M. Men&#x02019;s heightened risk of AIDS-related death: the legacy of gendered HIV testing and treatment strategies. AIDS. 2015;29(10):1123&#x02013;5.<pub-id pub-id-type="pmid">26035315</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Mangenah C, Mavhu W, Garcia DC, Gavi C, Mleya P, Chiwawa P, Chidawanyika S, Ncube G, Xaba S, Mugurungi O et al: Relative efficiency of demand creation strategies to increase voluntary medical male circumcision uptake: a study conducted as part of a randomised controlled trial in Zimbabwe. BMJ Glob Health 2021, 6(Suppl 4).</mixed-citation></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Lora</surname><given-names>WS</given-names></name><name><surname>Desmond</surname><given-names>N</given-names></name><name><surname>Obasi</surname><given-names>A</given-names></name><name><surname>Kumwenda</surname><given-names>M</given-names></name><name><surname>Taegtmeyer</surname><given-names>M</given-names></name><name><surname>Tolhurst</surname><given-names>R</given-names></name><name><surname>MacPherson</surname><given-names>EE</given-names></name></person-group><article-title>"I wanted evidence that my status had changed, so that is why I tested": experiences with HIV self-testing among female sex workers in Malawi</article-title><source>AIDS Care</source><year>2020</year><volume>32</volume><issue>sup2</issue><fpage>206</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1080/09540121.2020.1739212</pub-id><pub-id pub-id-type="pmid">32164420</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Lora WS, Desmond N, Obasi A, Kumwenda M, Taegtmeyer M, Tolhurst R, MacPherson EE. &#x0201c;I wanted evidence that my status had changed, so that is why I tested&#x0201d;: experiences with HIV self-testing among female sex workers in Malawi. AIDS Care. 2020;32(sup2):206&#x02013;13.<pub-id pub-id-type="pmid">32164420</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Witzel</surname><given-names>TC</given-names></name><name><surname>Eshun-Wilson</surname><given-names>I</given-names></name><name><surname>Jamil</surname><given-names>MS</given-names></name><name><surname>Tilouche</surname><given-names>N</given-names></name><name><surname>Figueroa</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>CC</given-names></name><name><surname>Reid</surname><given-names>D</given-names></name><name><surname>Baggaley</surname><given-names>R</given-names></name><name><surname>Siegfried</surname><given-names>N</given-names></name><name><surname>Burns</surname><given-names>FM</given-names></name><etal/></person-group><article-title>Comparing the effects of HIV self-testing to standard HIV testing for key populations: a systematic review and meta-analysis</article-title><source>BMC Med</source><year>2020</year><volume>18</volume><issue>1</issue><fpage>381</fpage><pub-id pub-id-type="doi">10.1186/s12916-020-01835-z</pub-id><pub-id pub-id-type="pmid">33267890</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Witzel TC, Eshun-Wilson I, Jamil MS, Tilouche N, Figueroa C, Johnson CC, Reid D, Baggaley R, Siegfried N, Burns FM, et al. Comparing the effects of HIV self-testing to standard HIV testing for key populations: a systematic review and meta-analysis. BMC Med. 2020;18(1):381.<pub-id pub-id-type="pmid">33267890</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Kumwenda</surname><given-names>MK</given-names></name><name><surname>Mavhu</surname><given-names>W</given-names></name><name><surname>Lora</surname><given-names>WS</given-names></name><name><surname>Chilongosi</surname><given-names>R</given-names></name><name><surname>Sikwesese</surname><given-names>S</given-names></name><name><surname>Taegtmeyer</surname><given-names>M</given-names></name></person-group><article-title>Feasibility and acceptability of a peer-led HIV self-testing model among female sex workers in Malawi: a qualitative study</article-title><source>BMJ Open</source><year>2021</year><volume>11</volume><issue>12</issue><fpage>e049248</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2021-049248</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Kumwenda MK, Mavhu W, Lora WS, Chilongosi R, Sikwesese S, Taegtmeyer M. Feasibility and acceptability of a peer-led HIV self-testing model among female sex workers in Malawi: a qualitative study. BMJ Open. 2021;11(12): e049248.</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Pillay</surname><given-names>Y</given-names></name><name><surname>Johnson</surname><given-names>L</given-names></name></person-group><article-title>World AIDS Day 2020: Reflections on global and South African progress and continuing challenges</article-title><source>South Afr J HIV Med</source><year>2021</year><volume>22</volume><issue>1</issue><fpage>1205</fpage><pub-id pub-id-type="doi">10.4102/sajhivmed.v22i1.1205</pub-id><pub-id pub-id-type="pmid">33824738</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Pillay Y, Johnson L. World AIDS Day 2020: Reflections on global and South African progress and continuing challenges. South Afr J HIV Med. 2021;22(1):1205.<pub-id pub-id-type="pmid">33824738</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">UNAIDS: Global AIDS Strategy 2021-2026: End Inequalities, End AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2021. Available: <ext-link ext-link-type="uri" xlink:href="https://www.unaids.org/en/resources/documents/2021/2021-2026-global-AIDS-strategy">https://www.unaids.org/en/resources/documents/2021/2021-2026-global-AIDS-strategy</ext-link>.</mixed-citation></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Mahy</surname><given-names>MI</given-names></name><name><surname>Sabin</surname><given-names>KM</given-names></name><name><surname>Feizzadeh</surname><given-names>A</given-names></name><name><surname>Wanyeki</surname><given-names>I</given-names></name></person-group><article-title>Progress towards 2020 global HIV impact and treatment targets</article-title><source>J Int AIDS Soc</source><year>2021</year><volume>24</volume><issue>Suppl 5</issue><fpage>e25779</fpage><pub-id pub-id-type="doi">10.1002/jia2.25779</pub-id><pub-id pub-id-type="pmid">34546655</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Mahy MI, Sabin KM, Feizzadeh A, Wanyeki I. Progress towards 2020 global HIV impact and treatment targets. J Int AIDS Soc. 2021;24(Suppl 5): e25779.<pub-id pub-id-type="pmid">34546655</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Gupta-Wright A, Barnabas RV, Ingold H, Duneton P, Abubakar I: HIV self-testing: lessons learnt and priorities for adaptation in a shifting landscape. BMJ Glob Health 2021, 6(Suppl 4).</mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">WHO: Consolidated guidelines on HIV testing services, 2019. Geneva: World Health Organization; 2020: Available: <ext-link ext-link-type="uri" xlink:href="https://iris.who.int/handle/10665/336323">https://iris.who.int/handle/10665/336323</ext-link>.</mixed-citation></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Eshun-Wilson</surname><given-names>I</given-names></name><name><surname>Jamil</surname><given-names>MS</given-names></name><name><surname>Witzel</surname><given-names>TC</given-names></name><name><surname>Glidded</surname><given-names>DV</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Le Trouneau</surname><given-names>N</given-names></name><name><surname>Ford</surname><given-names>N</given-names></name><name><surname>McGee</surname><given-names>K</given-names></name><name><surname>Kemp</surname><given-names>C</given-names></name><name><surname>Baral</surname><given-names>S</given-names></name><etal/></person-group><article-title>A Systematic Review and Network Meta-analyses to Assess the Effectiveness of Human Immunodeficiency Virus (HIV) Self-testing Distribution Strategies</article-title><source>Clin Infect Dis</source><year>2021</year><volume>73</volume><issue>4</issue><fpage>e1018</fpage><lpage>e1028</lpage><pub-id pub-id-type="doi">10.1093/cid/ciab029</pub-id><pub-id pub-id-type="pmid">34398952</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Eshun-Wilson I, Jamil MS, Witzel TC, Glidded DV, Johnson C, Le Trouneau N, Ford N, McGee K, Kemp C, Baral S, et al. A Systematic Review and Network Meta-analyses to Assess the Effectiveness of Human Immunodeficiency Virus (HIV) Self-testing Distribution Strategies. Clin Infect Dis. 2021;73(4):e1018&#x02013;28.<pub-id pub-id-type="pmid">34398952</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Jamil</surname><given-names>MS</given-names></name><name><surname>Eshun-Wilson</surname><given-names>I</given-names></name><name><surname>Witzel</surname><given-names>TC</given-names></name><name><surname>Siegfried</surname><given-names>N</given-names></name><name><surname>Figueroa</surname><given-names>C</given-names></name><name><surname>Chitembo</surname><given-names>L</given-names></name><name><surname>Msimanga-Radebe</surname><given-names>B</given-names></name><name><surname>Pasha</surname><given-names>MS</given-names></name><name><surname>Hatzold</surname><given-names>K</given-names></name><name><surname>Corbett</surname><given-names>E</given-names></name><etal/></person-group><article-title>Examining the effects of HIV self-testing compared to standard HIV testing services in the general population: A systematic review and meta-analysis</article-title><source>EClinicalMedicine</source><year>2021</year><volume>38</volume><fpage>100991</fpage><pub-id pub-id-type="doi">10.1016/j.eclinm.2021.100991</pub-id><pub-id pub-id-type="pmid">34278282</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Jamil MS, Eshun-Wilson I, Witzel TC, Siegfried N, Figueroa C, Chitembo L, Msimanga-Radebe B, Pasha MS, Hatzold K, Corbett E, et al. Examining the effects of HIV self-testing compared to standard HIV testing services in the general population: A systematic review and meta-analysis. EClinicalMedicine. 2021;38: 100991.<pub-id pub-id-type="pmid">34278282</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Kiptinness</surname><given-names>C</given-names></name><name><surname>Kuo</surname><given-names>AP</given-names></name><name><surname>Reedy</surname><given-names>AM</given-names></name><name><surname>Johnson</surname><given-names>CC</given-names></name><name><surname>Ngure</surname><given-names>K</given-names></name><name><surname>Wagner</surname><given-names>AD</given-names></name><name><surname>Ortblad</surname><given-names>KF</given-names></name></person-group><article-title>Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review</article-title><source>Curr HIV/AIDS Rep</source><year>2022</year><volume>19</volume><issue>5</issue><fpage>394</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1007/s11904-022-00617-x</pub-id><pub-id pub-id-type="pmid">35904695</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Kiptinness C, Kuo AP, Reedy AM, Johnson CC, Ngure K, Wagner AD, Ortblad KF. Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review. Curr HIV/AIDS Rep. 2022;19(5):394&#x02013;408.<pub-id pub-id-type="pmid">35904695</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>VJ</given-names></name><name><surname>Tan</surname><given-names>SC</given-names></name><name><surname>Earnest</surname><given-names>A</given-names></name><name><surname>Seong</surname><given-names>PS</given-names></name><name><surname>Tan</surname><given-names>HH</given-names></name><name><surname>Leo</surname><given-names>YS</given-names></name></person-group><article-title>User acceptability and feasibility of self-testing with HIV rapid tests</article-title><source>J Acquir Immune Defic Syndr</source><year>2007</year><volume>45</volume><issue>4</issue><fpage>449</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1097/QAI.0b013e318095a3f3</pub-id><pub-id pub-id-type="pmid">17554213</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Lee VJ, Tan SC, Earnest A, Seong PS, Tan HH, Leo YS. User acceptability and feasibility of self-testing with HIV rapid tests. J Acquir Immune Defic Syndr. 2007;45(4):449&#x02013;53.<pub-id pub-id-type="pmid">17554213</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Lippman</surname><given-names>SA</given-names></name><name><surname>Moran</surname><given-names>L</given-names></name><name><surname>Sevelius</surname><given-names>J</given-names></name><name><surname>Castillo</surname><given-names>LS</given-names></name><name><surname>Ventura</surname><given-names>A</given-names></name><name><surname>Treves-Kagan</surname><given-names>S</given-names></name><name><surname>Buchbinder</surname><given-names>S</given-names></name></person-group><article-title>Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study</article-title><source>AIDS Behav</source><year>2016</year><volume>20</volume><issue>4</issue><fpage>928</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1007/s10461-015-1236-2</pub-id><pub-id pub-id-type="pmid">26511864</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Lippman SA, Moran L, Sevelius J, Castillo LS, Ventura A, Treves-Kagan S, Buchbinder S. Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study. AIDS Behav. 2016;20(4):928&#x02013;38.<pub-id pub-id-type="pmid">26511864</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Ngoc</surname><given-names>BV</given-names></name><name><surname>Majam</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>K</given-names></name><name><surname>Tran</surname><given-names>T</given-names></name><name><surname>Hung</surname><given-names>MT</given-names></name><name><surname>Que</surname><given-names>AL</given-names></name><name><surname>Ngoc</surname><given-names>DB</given-names></name><name><surname>Le Duy</surname><given-names>CH</given-names></name></person-group><article-title>Acceptability, feasibility, and accuracy of blood-based HIV self-testing: A cross-sectional study in Ho Chi Minh City</article-title><source>Vietnam PLOS Glob Public Health</source><year>2023</year><volume>3</volume><issue>2</issue><fpage>e0001438</fpage><pub-id pub-id-type="doi">10.1371/journal.pgph.0001438</pub-id><pub-id pub-id-type="pmid">36962976</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Ngoc BV, Majam M, Green K, Tran T, Hung MT, Que AL, Ngoc DB, Le Duy CH. Acceptability, feasibility, and accuracy of blood-based HIV self-testing: A cross-sectional study in Ho Chi Minh City. Vietnam PLOS Glob Public Health. 2023;3(2): e0001438.<pub-id pub-id-type="pmid">36962976</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>MY</given-names></name><name><surname>Qian</surname><given-names>HZ</given-names></name><name><surname>Wang</surname><given-names>LJ</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Ding</surname><given-names>HF</given-names></name><name><surname>Ji</surname><given-names>YC</given-names></name><name><surname>Li</surname><given-names>DL</given-names></name><name><surname>Xiao</surname><given-names>D</given-names></name><name><surname>Hazlitt</surname><given-names>M</given-names></name><etal/></person-group><article-title>Home-based HIV testing for men who have sex with men in China: a novel community-based partnership to complement government programs</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>7</issue><fpage>e102812</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0102812</pub-id><pub-id pub-id-type="pmid">25051160</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Tao J, Li MY, Qian HZ, Wang LJ, Zhang Z, Ding HF, Ji YC, Li DL, Xiao D, Hazlitt M, et al. Home-based HIV testing for men who have sex with men in China: a novel community-based partnership to complement government programs. PLoS ONE. 2014;9(7): e102812.<pub-id pub-id-type="pmid">25051160</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Volk</surname><given-names>JE</given-names></name><name><surname>Lippman</surname><given-names>SA</given-names></name><name><surname>Grinsztejn</surname><given-names>B</given-names></name><name><surname>Lama</surname><given-names>JR</given-names></name><name><surname>Fernandes</surname><given-names>NM</given-names></name><name><surname>Gonzales</surname><given-names>P</given-names></name><name><surname>Hessol</surname><given-names>NA</given-names></name><name><surname>Buchbinder</surname><given-names>S</given-names></name></person-group><article-title>Acceptability and feasibility of HIV self-testing among men who have sex with men in Peru and Brazil</article-title><source>Int J STD AIDS</source><year>2016</year><volume>27</volume><issue>7</issue><fpage>531</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1177/0956462415586676</pub-id><pub-id pub-id-type="pmid">25971262</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Volk JE, Lippman SA, Grinsztejn B, Lama JR, Fernandes NM, Gonzales P, Hessol NA, Buchbinder S. Acceptability and feasibility of HIV self-testing among men who have sex with men in Peru and Brazil. Int J STD AIDS. 2016;27(7):531&#x02013;6.<pub-id pub-id-type="pmid">25971262</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>O'Reilly</surname><given-names>A</given-names></name><name><surname>Mavhu</surname><given-names>W</given-names></name><name><surname>Neuman</surname><given-names>M</given-names></name><name><surname>Kumwenda</surname><given-names>MK</given-names></name><name><surname>Johnson</surname><given-names>CC</given-names></name><name><surname>Sinjani</surname><given-names>G</given-names></name><name><surname>Indravudh</surname><given-names>P</given-names></name><name><surname>Choko</surname><given-names>A</given-names></name><name><surname>Hatzold</surname><given-names>K</given-names></name><name><surname>Corbett</surname><given-names>EL</given-names></name></person-group><article-title>Accuracy of and preferences for blood-based versus oral-fluid-based HIV self-testing in Malawi: a cross-sectional study</article-title><source>BMC Infect Dis</source><year>2024</year><volume>22</volume><issue>Suppl 1</issue><fpage>979</fpage><pub-id pub-id-type="doi">10.1186/s12879-024-09231-1</pub-id><pub-id pub-id-type="pmid">38566003</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">O&#x02019;Reilly A, Mavhu W, Neuman M, Kumwenda MK, Johnson CC, Sinjani G, Indravudh P, Choko A, Hatzold K, Corbett EL. Accuracy of and preferences for blood-based versus oral-fluid-based HIV self-testing in Malawi: a cross-sectional study. BMC Infect Dis. 2024;22(Suppl 1):979.<pub-id pub-id-type="pmid">38566003</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Napierala</surname><given-names>S</given-names></name><name><surname>Desmond</surname><given-names>NA</given-names></name><name><surname>Kumwenda</surname><given-names>MK</given-names></name><name><surname>Tumushime</surname><given-names>M</given-names></name><name><surname>Sibanda</surname><given-names>EL</given-names></name><name><surname>Indravudh</surname><given-names>P</given-names></name><name><surname>Hatzold</surname><given-names>K</given-names></name><name><surname>Johnson</surname><given-names>CC</given-names></name><name><surname>Baggaley</surname><given-names>RC</given-names></name><name><surname>Corbett</surname><given-names>L</given-names></name><etal/></person-group><article-title>HIV self-testing services for female sex workers, Malawi and Zimbabwe</article-title><source>Bull World Health Organ</source><year>2019</year><volume>97</volume><issue>11</issue><fpage>764</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.2471/BLT.18.223560</pub-id><pub-id pub-id-type="pmid">31673192</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Napierala S, Desmond NA, Kumwenda MK, Tumushime M, Sibanda EL, Indravudh P, Hatzold K, Johnson CC, Baggaley RC, Corbett L, et al. HIV self-testing services for female sex workers, Malawi and Zimbabwe. Bull World Health Organ. 2019;97(11):764&#x02013;76.<pub-id pub-id-type="pmid">31673192</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Okoboi</surname><given-names>S</given-names></name><name><surname>Lazarus</surname><given-names>O</given-names></name><name><surname>Castelnuovo</surname><given-names>B</given-names></name><name><surname>Nanfuka</surname><given-names>M</given-names></name><name><surname>Kambugu</surname><given-names>A</given-names></name><name><surname>Mujugira</surname><given-names>A</given-names></name><name><surname>King</surname><given-names>R</given-names></name></person-group><article-title>Peer distribution of HIV self-test kits to men who have sex with men to identify undiagnosed HIV infection in Uganda: A pilot study</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><issue>1</issue><fpage>e0227741</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0227741</pub-id><pub-id pub-id-type="pmid">31971991</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Okoboi S, Lazarus O, Castelnuovo B, Nanfuka M, Kambugu A, Mujugira A, King R. Peer distribution of HIV self-test kits to men who have sex with men to identify undiagnosed HIV infection in Uganda: A pilot study. PLoS ONE. 2020;15(1): e0227741.<pub-id pub-id-type="pmid">31971991</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Shava</surname><given-names>E</given-names></name><name><surname>Bogart</surname><given-names>LM</given-names></name><name><surname>Manyake</surname><given-names>K</given-names></name><name><surname>Mdluli</surname><given-names>C</given-names></name><name><surname>Maribe</surname><given-names>K</given-names></name><name><surname>Monnapula</surname><given-names>N</given-names></name><name><surname>Nkomo</surname><given-names>B</given-names></name><name><surname>Mosepele</surname><given-names>M</given-names></name><name><surname>Moyo</surname><given-names>S</given-names></name><name><surname>Mmalane</surname><given-names>M</given-names></name><etal/></person-group><article-title>Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><issue>11</issue><fpage>e0259508</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0259508</pub-id><pub-id pub-id-type="pmid">34748576</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Shava E, Bogart LM, Manyake K, Mdluli C, Maribe K, Monnapula N, Nkomo B, Mosepele M, Moyo S, Mmalane M, et al. Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana. PLoS ONE. 2021;16(11): e0259508.<pub-id pub-id-type="pmid">34748576</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Mekonnen</surname><given-names>H</given-names></name><name><surname>Manyazewal</surname><given-names>T</given-names></name><name><surname>Kajogoo</surname><given-names>VD</given-names></name><name><surname>Getachew Assefa</surname><given-names>D</given-names></name><name><surname>Gugsa Bekele</surname><given-names>J</given-names></name><name><surname>Tolossa Debela</surname><given-names>D</given-names></name></person-group><article-title>Advances in HIV self-testing: Systematic review of current developments and the road ahead in high-burden countries of Africa</article-title><source>SAGE Open Med</source><year>2024</year><volume>12</volume><fpage>20503121231220788</fpage><pub-id pub-id-type="doi">10.1177/20503121231220788</pub-id><pub-id pub-id-type="pmid">38162911</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Mekonnen H, Manyazewal T, Kajogoo VD, Getachew Assefa D, Gugsa Bekele J, Tolossa Debela D. Advances in HIV self-testing: Systematic review of current developments and the road ahead in high-burden countries of Africa. SAGE Open Med. 2024;12:20503121231220788.<pub-id pub-id-type="pmid">38162911</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Ingold</surname><given-names>H</given-names></name><name><surname>Mwerinde</surname><given-names>O</given-names></name><name><surname>Ross</surname><given-names>AL</given-names></name><name><surname>Leach</surname><given-names>R</given-names></name><name><surname>Corbett</surname><given-names>EL</given-names></name><name><surname>Hatzold</surname><given-names>K</given-names></name><name><surname>Johnson</surname><given-names>CC</given-names></name><name><surname>Ncube</surname><given-names>G</given-names></name><name><surname>Nyirenda</surname><given-names>R</given-names></name><name><surname>Baggaley</surname><given-names>RC</given-names></name></person-group><article-title>The Self-Testing AfRica (STAR) Initiative: accelerating global access and scale-up of HIV self-testing</article-title><source>J Int AIDS Soc</source><year>2019</year><volume>22</volume><issue>Suppl 1</issue><fpage>e25249</fpage><pub-id pub-id-type="doi">10.1002/jia2.25249</pub-id><pub-id pub-id-type="pmid">30907517</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Ingold H, Mwerinde O, Ross AL, Leach R, Corbett EL, Hatzold K, Johnson CC, Ncube G, Nyirenda R, Baggaley RC. The Self-Testing AfRica (STAR) Initiative: accelerating global access and scale-up of HIV self-testing. J Int AIDS Soc. 2019;22(Suppl 1): e25249.<pub-id pub-id-type="pmid">30907517</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="other">Matsimela K, Sande LA, Mostert C, Majam M, Phiri J, Zishiri V, Madondo C, Khama S, Chidarikire T, d'Elbee M et al: The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa. BMJ Glob Health 2021, 6(Suppl 4).</mixed-citation></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Indravudh</surname><given-names>PP</given-names></name><name><surname>Sibanda</surname><given-names>EL</given-names></name><name><surname>d'Elb&#x000e9;e</surname><given-names>M</given-names></name><name><surname>Kumwenda</surname><given-names>MK</given-names></name><name><surname>Ringwald</surname><given-names>B</given-names></name><name><surname>Maringwa</surname><given-names>G</given-names></name><name><surname>Simwinga</surname><given-names>M</given-names></name><name><surname>Nyirenda</surname><given-names>LJ</given-names></name><name><surname>Johnson</surname><given-names>CC</given-names></name><name><surname>Hatzold</surname><given-names>K</given-names></name><etal/></person-group><article-title>&#x02018;I will choose when to test, where I want to test&#x02019;: investigating young people&#x02019;s preferences for HIV self-testing in Malawi and Zimbabwe</article-title><source>AIDS</source><year>2017</year><volume>31</volume><issue>Suppl 3</issue><fpage>S203</fpage><lpage>S212</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000001516</pub-id><pub-id pub-id-type="pmid">28665878</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Indravudh PP, Sibanda EL, d&#x02019;Elb&#x000e9;e M, Kumwenda MK, Ringwald B, Maringwa G, Simwinga M, Nyirenda LJ, Johnson CC, Hatzold K, et al. &#x02018;I will choose when to test, where I want to test&#x02019;: investigating young people&#x02019;s preferences for HIV self-testing in Malawi and Zimbabwe. AIDS. 2017;31(Suppl 3):S203&#x02013;12.<pub-id pub-id-type="pmid">28665878</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Sibanda EL, d'Elbee M, Maringwa G, Ruhode N, Tumushime M, Madanhire C, Ong JJ, Indravudh P, Watadzaushe C, Johnson CC et al: Applying user preferences to optimize the contribution of HIV self-testing to reaching the "first 90" target of UNAIDS Fast-track strategy: results from discrete choice experiments in Zimbabwe. J Int AIDS Soc 2019, 22 Suppl 1(Suppl Suppl 1):e25245.</mixed-citation></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Sibanda</surname><given-names>EL</given-names></name><name><surname>Mavhu</surname><given-names>W</given-names></name></person-group><article-title>Secondary HIV self-test distribution increases male partner testing</article-title><source>Lancet Glob Health</source><year>2021</year><volume>9</volume><issue>12</issue><fpage>e1632</fpage><lpage>e1633</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(21)00450-2</pub-id><pub-id pub-id-type="pmid">34735863</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Sibanda EL, Mavhu W. Secondary HIV self-test distribution increases male partner testing. Lancet Glob Health. 2021;9(12):e1632&#x02013;3.<pub-id pub-id-type="pmid">34735863</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">WHO and ILO: Policy Brief: HIV self-testing at workplaces: approaches to implementation and sustainable financing. Geneva: World Health Organization &#x00026; International Labour Organization; 2022. Available: <ext-link ext-link-type="uri" xlink:href="https://iris.who.int/bitstream/handle/10665/354358/9789240040632-eng.pdf">https://iris.who.int/bitstream/handle/10665/354358/9789240040632-eng.pdf</ext-link>.</mixed-citation></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Nsereko</surname><given-names>GM</given-names></name><name><surname>Musanje</surname><given-names>K</given-names></name><name><surname>Ayesiga</surname><given-names>ER</given-names></name><name><surname>Kobusingye</surname><given-names>LK</given-names></name><name><surname>Namubiru</surname><given-names>R</given-names></name><name><surname>Sempala</surname><given-names>M</given-names></name><name><surname>Kiwala</surname><given-names>C</given-names></name><name><surname>Baluku</surname><given-names>MM</given-names></name></person-group><article-title>A workplace-based HIV self-testing intervention as a determinant for self-testing knowledge, beliefs, and use among unskilled workers in Wakiso Uganda</article-title><source>BMC Public Health</source><year>2025</year><volume>25</volume><issue>1</issue><fpage>187</fpage><pub-id pub-id-type="doi">10.1186/s12889-025-21471-7</pub-id><pub-id pub-id-type="pmid">39819499</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Nsereko GM, Musanje K, Ayesiga ER, Kobusingye LK, Namubiru R, Sempala M, Kiwala C, Baluku MM. A workplace-based HIV self-testing intervention as a determinant for self-testing knowledge, beliefs, and use among unskilled workers in Wakiso Uganda. BMC Public Health. 2025;25(1):187.<pub-id pub-id-type="pmid">39819499</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>P</given-names></name><name><surname>Dworkin</surname><given-names>SL</given-names></name><name><surname>Tong</surname><given-names>S</given-names></name><name><surname>Banks</surname><given-names>I</given-names></name><name><surname>Shand</surname><given-names>T</given-names></name><name><surname>Yamey</surname><given-names>G</given-names></name></person-group><article-title>The men's health gap: men must be included in the global health equity agenda</article-title><source>Bull World Health Organ</source><year>2014</year><volume>92</volume><issue>8</issue><fpage>618</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.2471/BLT.13.132795</pub-id><pub-id pub-id-type="pmid">25197149</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Baker P, Dworkin SL, Tong S, Banks I, Shand T, Yamey G. The men&#x02019;s health gap: men must be included in the global health equity agenda. Bull World Health Organ. 2014;92(8):618&#x02013;20.<pub-id pub-id-type="pmid">25197149</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Ky-Zerbo</surname><given-names>O</given-names></name><name><surname>Desclaux</surname><given-names>A</given-names></name><name><surname>Boye</surname><given-names>S</given-names></name><name><surname>Vautier</surname><given-names>A</given-names></name><name><surname>Rouveau</surname><given-names>N</given-names></name><name><surname>Kouadio</surname><given-names>BA</given-names></name><name><surname>Fotso</surname><given-names>AS</given-names></name><name><surname>Pourette</surname><given-names>D</given-names></name><name><surname>Maheu-Giroux</surname><given-names>M</given-names></name><name><surname>Sow</surname><given-names>S</given-names></name><etal/></person-group><article-title>Willingness to use and distribute HIV self-test kits to clients and partners: A qualitative analysis of female sex workers' collective opinion and attitude in Cote d'Ivoire, Mali, and Senegal</article-title><source>Womens Health (Lond)</source><year>2022</year><volume>18</volume><fpage>17455057221092268</fpage><pub-id pub-id-type="doi">10.1177/17455057221092268</pub-id><pub-id pub-id-type="pmid">35435052</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Ky-Zerbo O, Desclaux A, Boye S, Vautier A, Rouveau N, Kouadio BA, Fotso AS, Pourette D, Maheu-Giroux M, Sow S, et al. Willingness to use and distribute HIV self-test kits to clients and partners: A qualitative analysis of female sex workers&#x02019; collective opinion and attitude in Cote d&#x02019;Ivoire, Mali, and Senegal. Womens Health (Lond). 2022;18:17455057221092268.<pub-id pub-id-type="pmid">35435052</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Mee</surname><given-names>P</given-names></name><name><surname>Neuman</surname><given-names>M</given-names></name><name><surname>Kumwenda</surname><given-names>M</given-names></name><name><surname>Lora</surname><given-names>WS</given-names></name><name><surname>Sikwese</surname><given-names>S</given-names></name><name><surname>Sambo</surname><given-names>M</given-names></name><name><surname>Fielding</surname><given-names>K</given-names></name><name><surname>Indravudh</surname><given-names>PP</given-names></name><name><surname>Hatzold</surname><given-names>K</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><etal/></person-group><article-title>Experience of social harms among female sex workers following HIV self-test distribution in Malawi: results of a cohort study</article-title><source>BMC Infect Dis</source><year>2024</year><volume>22</volume><issue>Suppl 1</issue><fpage>978</fpage><pub-id pub-id-type="doi">10.1186/s12879-024-09178-3</pub-id><pub-id pub-id-type="pmid">38468208</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Mee P, Neuman M, Kumwenda M, Lora WS, Sikwese S, Sambo M, Fielding K, Indravudh PP, Hatzold K, Johnson C, et al. Experience of social harms among female sex workers following HIV self-test distribution in Malawi: results of a cohort study. BMC Infect Dis. 2024;22(Suppl 1):978.<pub-id pub-id-type="pmid">38468208</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Mavhu</surname><given-names>W</given-names></name><name><surname>Rowley</surname><given-names>E</given-names></name><name><surname>Thior</surname><given-names>I</given-names></name><name><surname>Kruse-Levy</surname><given-names>N</given-names></name><name><surname>Mugurungi</surname><given-names>O</given-names></name><name><surname>Ncube</surname><given-names>G</given-names></name><name><surname>Leclerc-Madlala</surname><given-names>S</given-names></name></person-group><article-title>Sexual behavior experiences and characteristics of male-female partnerships among HIV positive adolescent girls and young women: Qualitative findings from Zimbabwe</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><issue>3</issue><fpage>e0194732</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0194732</pub-id><pub-id pub-id-type="pmid">29566062</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Mavhu W, Rowley E, Thior I, Kruse-Levy N, Mugurungi O, Ncube G, Leclerc-Madlala S. Sexual behavior experiences and characteristics of male-female partnerships among HIV positive adolescent girls and young women: Qualitative findings from Zimbabwe. PLoS ONE. 2018;13(3): e0194732.<pub-id pub-id-type="pmid">29566062</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Mupambireyi</surname><given-names>Z</given-names></name><name><surname>Simms</surname><given-names>V</given-names></name><name><surname>Mavhu</surname><given-names>W</given-names></name><name><surname>Mutasa</surname><given-names>C</given-names></name><name><surname>Matsikire</surname><given-names>E</given-names></name><name><surname>Ricotta</surname><given-names>A</given-names></name><name><surname>Pascoe</surname><given-names>M</given-names></name><name><surname>Shamu</surname><given-names>T</given-names></name><name><surname>Senzanje</surname><given-names>B</given-names></name><name><surname>Pierotti</surname><given-names>C</given-names></name><etal/></person-group><article-title>Clinical and psychosocial context of HIV perinatally infected young mothers in Harare, Zimbabwe: A longitudinal mixed-methods study</article-title><source>PLoS ONE</source><year>2025</year><volume>20</volume><issue>1</issue><fpage>e0315299</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0315299</pub-id><pub-id pub-id-type="pmid">39792915</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Mupambireyi Z, Simms V, Mavhu W, Mutasa C, Matsikire E, Ricotta A, Pascoe M, Shamu T, Senzanje B, Pierotti C, et al. Clinical and psychosocial context of HIV perinatally infected young mothers in Harare, Zimbabwe: A longitudinal mixed-methods study. PLoS ONE. 2025;20(1): e0315299.<pub-id pub-id-type="pmid">39792915</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>